Navigation Links
Cell Therapeutics, Inc. Announces Issuance of $23.25 Million in New Convertible Senior Notes in Exchange for $36.08 Million of Existing Convertible Senior Subordinated and Subordinated Notes
Date:12/13/2007

Exchange retired $12.83 million in existing current 2008 convertible notes and extended the maturity to 2011 on an additional $23.25 million in 2008

convertible notes

SEATTLE, Dec. 13 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. ("CTI" or the "Company") (Nasdaq and MTAX: CTIC) today announced that it issued approximately $23.25 million of its new 5.75% Convertible Senior Notes (the "New Notes") due 2011 and 5,459,574 shares of its common stock, no par value (the "Common Stock") in exchange for approximately $10.5 million of its outstanding 5.75% Convertible Senior Subordinated Notes due 2008 (the "Senior Subordinated Notes") and approximately $25.6 of its outstanding 5.75% Convertible Subordinated Notes due 2008 (the "Subordinated Notes"). The New Notes and Common Stock were issued in a private placement exempt from the registration requirements of the Securities Act of 1933, as amended (the "Securities Act"). Approximately $19.8 million in Senior Subordinated Notes and Subordinated Notes remain outstanding and mature in June 2008.

The New Notes bear interest at 5.75% per annum and are convertible for shares of CTI common stock at the rate of 333.33 shares per $1,000 principal amount of New Notes, which is equivalent to an initial conversion price of approximately $3.00 per share. The New Notes rank equal in right of payment with all existing and future senior indebtedness of CTI, including the Corporation's 6.75% Convertible Senior Notes due 2010 and 7.5% Convertible Senior Notes due 2011, and rank senior in right of payment to the Corporation's currently outstanding Senior Subordinated Notes, Subordinated Notes and 4% Convertible Senior Subordinated Notes due 2010.

The New Notes and the Common Stock to be issued pursuant to the exchange agreement have not been registered under the Securities Act or any state securities laws. The New Notes and the Common Stock issued pursuant to the exchange agreement an
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
2. Cell Therapeutics, Inc. Takes Corrective Actions in Response to Nasdaq Determination
3. ARYx Therapeutics, Inc. Files Registration Statement for Initial Public Offering
4. Nile Therapeutics, Inc. Adds to Executive Management Team
5. Cell Therapeutics, Inc. (CTI) Receives SPA Approval from FDA and Launches Gender-Specific Phase III Trial for Advanced Non-Small Cell Lung Cancer
6. Founder of ILEX Oncology and Triton Biosciences, Richard Love, Joins Board of Directors of Cell Therapeutics, Inc. (CTI)
7. Cell Therapeutics, Inc. (CTI) Announces 2007 Annual Shareholders Meeting Results
8. Northwest Biotherapeutics, Inc. Announces Appointment of Chief Financial Officer
9. Nile Therapeutics, Inc. to Present at Upcoming BIO Investor Forum
10. Hyperion Therapeutics, Inc. Announces Senior Management Team and $15M Financing Event
11. Cell Therapeutics, Inc. (CTI) BIO Presentation to Be Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2008)...rate research of potential vaccine for low-resourc...Md., Dec. 4 The biotech company Le... organization PATH announced today a partnership t...ine. PATH will initially invest $3 million over 27...lopment of a H5N1 virus-like particle (VLP) protot...
(Date:12/4/2008)...December 4 AC Immune SA, a leader,...d today that the World,Economic Forum has elected...omplishments as an innovation leader and for its b...act on business and society. , Furthermore,...t clinical,milestones in the development of innov...
(Date:12/4/2008)... 4 Raymond J. De Hont, C...poration (NYSE: MPR ), announced today that the C...ecember 3, 2008, declared a quarterly dividend of ...holders of record at the close of business on Febr...crease over the same period last year. , , ...
(Date:12/4/2008)...c. 4 A 60-year-old,pros...e first person in France,to be treated using Rapi...NYSE: VAR ) for fast and precise forms of intens...eatments at the CRLC Val D,Aurelle - Paul Lamarque...faster than conventional IMRT,treatments. Dr. Pas...
Breaking Biology Technology:Lentigen Corporation and PATH Announce Partnership on Innovative Vaccine for Pandemic Influenza 2Lentigen Corporation and PATH Announce Partnership on Innovative Vaccine for Pandemic Influenza 3Technology Pioneer 2009 - AC Immune Highlights Significant Clinical Milestones in Alzheimer's Disease Drug Development 2Met-Pro Corporation Declares Quarterly Dividend 2Prostate Cancer Patient in Montpellier Becomes First Cancer Patient in France Treated with Varian's RapidArc(TM) Radiotherapy 2Prostate Cancer Patient in Montpellier Becomes First Cancer Patient in France Treated with Varian's RapidArc(TM) Radiotherapy 3
... Every corporation has a face, captured by its n...image-delivery system to push that name in the mar...te image is out there and is fully exposed. Follow...question is not which one is best, but which is th... if they really ring the cash registers, otherwise...
... Craig Schiefelbein stands with one of his compa...uld have thought that there could be a business op...board boxes? , ,Strange as it may seem, the opport...olleagues at Paragon Development Systems (PDS) a...loped an unusual service that makes it easier for ...
... Madison, Wis. The National Institute of Inform...n has signed a $200,000 contract with the Universi... uses for Croquet , an open-source operating syst... October. , ,Croquet is a peer-to-peer network arc...ource sharing among large numbers of users. , ,Pri...
... In 1975, the United States was third among all na...earned science and engineering degrees. Today, it ... and Italy. Unless that slide in scientific compet... security will be threatened. , ,That was the conc...nal Science Board, a federal advisory panel that h...
Other Biology Technology:Five faces of corporate image 2Five faces of corporate image 3PDS discovers golden opportunity In 323 dumpsters worth of trash 2PDS discovers golden opportunity In 323 dumpsters worth of trash 3Action now can help avoid the coming shortage of math and science grads 2Action now can help avoid the coming shortage of math and science grads 3
(Date:12/3/2008)... conference will take place December 14-17, 2008 a...the Negev under the auspices of BGU,s Jacob Blaust...the co-sponsors of the conference are the United N...zation (UNESCO), Israel,s Ministry for Foreign Aff...l Aviv, and Netafim, the global leader in smart wa...
(Date:12/3/2008)...desonide sprays can be regarded as safe for pregna...died though , Women can usually keep using the... pregnant. Budesonide sprays are the best studied ...essential medicines are necessary however. Accordi...ncy in Health Care (IQWiG), more data from trials ...
(Date:12/3/2008)...HINGTON Synthetic biology promises to enable chea...on people who suffer from malaria, and to create i... energy problems. But the science and its applica...ists playing God? Are these scientists purposely ...hetic biology researchers unintentionally equippin...
(Date:12/2/2008)...ichland, Wash. -- DNA sequencing is easier than ev...g up. An award-winning computer program now shows ...ive and intuitive, helping researchers find hidden...searchers from the Department of Energy,s Pacific ...ll" for their entry at the Supercomputing ,08 High...
Breaking Biology News(10 mins):Ben-Gurion University of the Negev to host 2Pregnant women with asthma can be more confident about some medicines 2Synthetic biology: Is ethics a showstopper? 2PNNL researchers earn top honors at Supercomputing conference 2PNNL researchers earn top honors at Supercomputing conference 3New Study Shows Lower Costs Increased Consumer Engagement in Account Based Health Plans 4257 1New Study Shows Lower Costs Increased Consumer Engagement in Account Based Health Plans 4257 2TriCipher Joins SAFE BioPharma Association Vendor Partner Program 1406 1TriCipher Joins SAFE BioPharma Association Vendor Partner Program 1406 2From terror to joy 3A faced with death our minds turn to happier thoughts 4251 1From terror to joy 3A faced with death our minds turn to happier thoughts 4251 2Are some men predisposed to pedophilia 3F 907 1
...man genome project, researchers at Dana-Farber Can...ad Institute of Harvard and MIT, and other collabo...roach to drug discovery that matches diseases with...ased on cells, distinctive gene activity profiles,...g published in the September 29 issue of Science a...
... And yet, our "taste" for certain flavors and food...tired of eating the same old thing. , Now, a new ...out what,s going on in the brain when we taste som...we once hated. , And although the study used rat...r understanding the way we perceive pleasure ?and ...
...ological, social and emotional dynamics of day-to-...hen older adults go to bed lonely, sad or overwhel... after waking the next morning. , Elevated levels ...on, obesity and other health problems when chronic...at it is time to rev up to deal with loneliness an...
...ple sclerosis (MS) carry a population of immune ce...s, which causes mononucleosis and may contribute t...role in MS. However, the mechanism linking the vir...ists think that MS--which can cause vision problem...on and balance--is a result of the immune system a...
Other Biology News:Scientists use gene signatures to match cancer and other diseases with potentially effective drugs 2Scientists use gene signatures to match cancer and other diseases with potentially effective drugs 3Tastes great! Study shows brain's response to pleasing -- and changing -- tastes 2Tastes great! Study shows brain's response to pleasing -- and changing -- tastes 3Adults who go to bed lonely get stress hormone boost next morning 2Adults who go to bed lonely get stress hormone boost next morning 3Epstein-Barr virus might kick-start multiple sclerosis 2Epstein-Barr virus might kick-start multiple sclerosis 3Epstein-Barr virus might kick-start multiple sclerosis 4
Mouse monoclonal antibody raised against a partial recombinant CRKRS. NCBI Entrez Gene ID = CRKRS
Mouse polyclonal antibody raised against a partial recombinant PPP4C. Immunogen: PPP4C (NP_002711, 218 a.a. ~ 308 a.a) partial recombinant protein with GST tag. Accession Number: NM_002720
Rabbit polyclonal antibody to GluR2
The E. coli protein sample is a complex protein sample, tested to give a consistent pattern when used with ReadyPrep 2-D starter kit rehydration and sample buffer. This sample can be used as a contro
Biology Products: